A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia With High Platelet Desialylation Level

Trial Profile

A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia With High Platelet Desialylation Level

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Oseltamivir (Primary) ; Dexamethasone
  • Indications Idiopathic thrombocytopenic purpura
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2017.
    • 18 Apr 2016 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2017.
    • 18 Apr 2016 Planned initiation date changed to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top